<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="– review &amp;amp; editing1*[1], Department of Immunology and Infectious Diseases," exact="Harvard T.H. Chan School of Public Health," post="Boston, MA, United States of America[2], College of Medicine,"/>
 <result pre="This study was supported by the McLennan Family Fund -" exact="Harvard T.H. Chan School of Public Health" post="Dean’s Challenge grant. Additional support from NIH-National Human Genome"/>
 <result pre="The protocols used in this study were approved by the" exact="Health Research" post="Ethics Committee at the College of Medicine, University of"/>
 <result pre="(CM/HREC/09/16/055) and by the Internal Review Board (IRB) at the" exact="Harvard T.H. Chan School of Public Health" post="(Harvard Chan), Boston, USA (Protocol number IRB16-1321). All study"/>
 <result pre="succumbed to infection. Nigeria was declared EBOV free by the" exact="World Health Organization" post="on 20 October 2014. Between August and November 2017,"/>
 <result pre="EBOV infections are not new phenomena. Using an immunofluorescence assay," exact="World Health Organization" post="researchers identified EBOV-infected individuals who had symptoms that ranged"/>
</results>
